Key result
Percutaneous AngioVac successfully removes a large right atrial clot, avoiding high-risk redo-sternotomy.
Why the study?
A very high-risk redo sternotomy in a Jehovah's Witness patient with a large right atrial clot requires alternative treatment approaches.
The AngioVac device offers a potentially lifesaving, minimally invasive alternative for right atrial clot extraction in patients at prohibitive risk for redo-sternotomy.
May support percutaneous extraction in prohibitive-risk redo cases; hypothesis-generating and requires prospective validation before practice change.
We report the novel use of the AngioVac device in a percutaneous hybrid approach to remove a large right atrial clot as an effective and potentially lifesaving alternative to a very high-risk redo-sternotomy in a Jehovah's Witness patient.
No takes yet. Share an insight, caveat, or question.
Pillai et al. (2012) studied this question. A percutaneous hybrid approach using the AngioVac device effectively removed a large right atrial clot, avoiding a high-risk redo-sternotomy in a Jehovah's Witness patient.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: